Diagnos Laboratorium Utama

Jakarta, Indonesia Founded: 2017 • Age: 9 yrs
Diagnostic test kits are manufactured for healthcare applications in Indonesia.
Request Access

About Diagnos Laboratorium Utama

Diagnos Laboratorium Utama is a company based in Jakarta (Indonesia) founded in 2017.. The company has 96 employees as of December 31, 2024. Diagnos Laboratorium Utama offers products and services including Genetic Testing and Medical Check-Up.

  • Headquarter Jakarta, Indonesia
  • Employees 96 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Pt Diagnos Laboratorium Utama Tbk
Operational Areas
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
    $10.11 M (USD)
    11.93
    as on Dec 31, 2024
  • Net Profit
    $46.34 K (USD)
    0
    as on Dec 31, 2024
  • EBITDA
    $1.06 M (USD)
    2758.08
    as on Dec 31, 2024
  • Latest Funding Round
    $3.48 M (USD), Debt – Conventional

    Mar 31, 2022

  • Investors
  • Employee Count
    96

    as on Dec 31, 2024

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Diagnos Laboratorium Utama

Diagnos Laboratorium Utama is a publicly listed company on the IDX with ticker symbol DGNS in Indonesia, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: IDX · Ticker: DGNS . Sector: Health services · Indonesia

Products & Services of Diagnos Laboratorium Utama

Diagnos Laboratorium Utama offers a comprehensive portfolio of products and services, including Genetic Testing and Medical Check-Up. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Genetic examinations are conducted by Diagnos to assess health risks and hereditary conditions, with services like DNAHope being utilized for accurate results.

Routine medical check-ups are provided by Diagnos, including homecare options and SARS-COV-2 testing, which are made available through various convenient channels.

Funding Insights of Diagnos Laboratorium Utama

  • Total Funding
  • Total Rounds 1
  • Last Round Debt – Conventional — $3.5M
  • First Round

    (31 Mar 2022)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2022 Amount Debt – Conventional - Diagnos Laboratorium Utama Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Diagnos Laboratorium Utama

Diagnos Laboratorium Utama has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include Bank Central Asia. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Commercial banking services are offered to individuals and corporates.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Diagnos Laboratorium Utama

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Diagnos Laboratorium Utama

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Diagnos Laboratorium Utama Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Diagnos Laboratorium Utama

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Diagnos Laboratorium Utama

Frequently Asked Questions about Diagnos Laboratorium Utama

When was Diagnos Laboratorium Utama founded?

Diagnos Laboratorium Utama was founded in 2017 and raised its 1st funding round 5 years after it was founded.

Where is Diagnos Laboratorium Utama located?

Diagnos Laboratorium Utama is headquartered in Jakarta, Indonesia. It is registered at Jakarta, Jakarta, Indonesia.

How many employees does Diagnos Laboratorium Utama have?

As of Dec 31, 2024, the latest employee count at Diagnos Laboratorium Utama is 96.

What is the annual revenue of Diagnos Laboratorium Utama?

Annual revenue of Diagnos Laboratorium Utama is $10.11M as on Dec 31, 2024.

What does Diagnos Laboratorium Utama do?

Diagnos Laboratorium Utama was established in 2017 in Jakarta, Indonesia, as a manufacturer within the healthcare sector. Diagnostic test kits are produced by the company to support medical diagnostics. Operations are centered on kit development and production, with a focus on reliability for clinical use. The firm is led by Managing Director Dennis Jacobus, and activities are conducted primarily in Indonesia to meet regional demands.

What products or services does Diagnos Laboratorium Utama offer?

Diagnos Laboratorium Utama offers Genetic Testing and Medical Check-Up.

Is Diagnos Laboratorium Utama publicly traded?

Yes, Diagnos Laboratorium Utama is publicly traded on IDX under the ticker symbol DGNS.

Who are Diagnos Laboratorium Utama's investors?

Diagnos Laboratorium Utama has 1 investor. Key investors include Bank Central Asia.

What is Diagnos Laboratorium Utama's ticker symbol?

The ticker symbol of Diagnos Laboratorium Utama is DGNS on IDX.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available